Gene · 5987
Papers2,241
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,241
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| In silico Analysis of CHD4 Mutations Reveals Domain-Specific Impacts on Cardiovascular Disorders Among Patients With Rare Diseases. | Hum Mutat | 2026 | 41756679 | PubTator, text mining | PubMed |
| TRIM proteins as emerging regulators of immune pathways: potential therapeutic targets in immune-related disorders. | Front Immunol | 2026 | 41756277 | PubTator, text mining | PubMed |
| Genetics and Epigenetics of Obsessive-Compulsive Disorder. | Genes (Basel) | 2026 | 41751572 | PubTator, text mining | PubMed |
| Extracellular vesicles and their role in Lupus Nephritis: A scoping review. | J Transl Autoimmun | 2026 | 41732236 | PubTator, text mining | PubMed |
| The Tomato Transcription Factor RAV Affects the Systemic Infection of TYLCV by Interacting With V2. | Mol Plant Pathol | 2026 | 41731338 | PubTator, text mining | PubMed |
| ASCT2 palmitoylation regulated by JNK1-ZDHHC14 axis orchestrates glutamine metabolism and NSCLC progression. | Cell Discov | 2026 | 41730846 | PubTator, text mining | PubMed |
| Biallelic DAW1 variants reveal tissue-specific role in heterotaxy without primary ciliary dyskinesia. | Res Sq | 2026 | 41727625 | PubTator, text mining | PubMed |
| Targetome profile of hsa-miR-93-5p is resistant to isoform formation in prostate adenocarcinoma. | PeerJ | 2026 | 41727220 | PubTator, text mining | PubMed |
| Spatiotemporal dynamics of Mcl-1 abundance and its influence on apoptosis susceptibility. | bioRxiv | 2026 | 41727085 | PubTator, text mining | PubMed |
| Upregulation of Gfi1 induced by LSD1 inhibitor protects against cisplatin-induced ototoxicity through attenuating pyroptosis. | Exp Cell Res | 2026 | 41565046 | PubTator, text mining | PubMed |
| MYC-driven TRIM27 upregulation promotes prostate cancer progression by enhancing CANX ubiquitination and activating PI3K/AKT signaling. | Funct Integr Genomics | 2026 | 41557161 | PubTator, text mining | PubMed |
| Immune activation and response dynamics of human iPSC-derived macrophages in tuberculosis infection models. | Clin Transl Immunology | 2026 | 41541231 | PubTator, text mining | PubMed |
| A CRISPR-based genome-wide loss-of-function screen defines a role of host metabolism in regulating hepatitis B virus infection. | Mol Ther | 2026 | 41332134 | PubTator, text mining | PubMed |
| Observing biological spatio-angular structures and dynamics with statistical image reconstruction and polarized fluorescence microscopy. | bioRxiv | 2025 | 41480145 | PubTator, text mining | PubMed |
| TRIM27: A Bifunctional Biomarker for Immune Microenvironment Regulation and Prognostic Assessment in Skin Cutaneous Melanoma. | Biomed Environ Sci | 2025 | 41472464 | PubTator, text mining | PubMed |
| PDLIM2 deficiency mediated by PBXIP1 promotes the proliferation of HCC cells through reducing the polyubiquitination and degradation of TRIM27. | Eur J Med Res | 2025 | 41340074 | PubTator, text mining | PubMed |
| Construction of Five Epithelial Immune-Related Gene Signatures and Verification of OPRK1 as a Prognostic Biomarker for Prostate Cancer. | Arch Esp Urol | 2025 | 41111380 | PubTator, text mining | PubMed |
| JIP4 and RILPL1 utilize opposing motor force to dynamically regulate lysosomal tubulation. | J Cell Biol | 2025 | 40990465 | PubTator, text mining | PubMed |
| Slice-PASEF: Maximising Ion Utilisation in LC-MS Proteomics. | bioRxiv | 2025 | 40950106 | PubTator, text mining | PubMed |
| USP7 overexpression prevents the progression of clear cell renal cell carcinoma by enhancing pyroptosis via TRIP12 deubiquitination. | Cancer Biol Ther | 2025 | 40947978 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5987/papers?page=2